Published May 27, 2022 | Version v1
Journal article Open

Uterine fibroids: synthesis of modern knowledge. Literature review

Creators

  • 1. SI "O.M. Lukyanova Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine"; State Scientific Institution "Center for Innovative Medical Technologies of the NAS of Ukraine", Kyiv, Ukraine
  • 2. SI "O.M. Lukyanova Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine"; SSI "Center for Innovative Medical Technologies of the NAS of Ukraine», Kyiv, Ukraine
  • 3. SI "O.M. Lukyanova Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine", Kyiv , Ukraine
  • 4. О.О. Bogomolets National Medical University, Kyiv , Ukraine

Description

Uterine fibroids is an extremely common tumor of the female reproductive system in the population. The problem of this pathology is the diversity of symptoms, mediated by the variety of sizes and locations of myomas, significant impact on reproductive function and frequent misunderstanding of the tumor nature, which leads to unwarranted hysterectomies, even among young women.
Authors review the literature on the basis of modern guidelines, which reveals the potential of preserving methods of treatment of fibroids. It is also attempted to answer the most common questions about this pathology.
The incidence of uterine fibroids increases with age. Fibroids are hormone dependent tumors, but the obvious cause has not yet been identified, although various risk factors are known, both modified (e.g., obesity, parity) and unmodified (race, age, etc.). Diagnosis of fibroids is simple – just an examination and ultrasound of the pelvis. Among the organ preservation methods of treatment are currently known medicinal (some of them can be used as mono-method or in combination with other methods), minimally invasive (among which stands out uterine artery embolization, as the most studied, effective and safe method) and surgical – conservative myomectomy, which can be performed by different approaches (laparoscopic, hysteroscopic or laparotomy) depending on the number and location of fibroids.
This review considers the issues of fertility in uterine fibroids and after organ preservation technologies for its treatment. Differential diagnosis of uterine fibroids with leiomyosarcoma – a rare tumor and its diagnosis is quite difficult.
The development of modern medical science, combining specialties with the formation of multidisciplinary teams (as in the case of collaboration with endovascular surgeons to perform uterine artery embolization) and use of an individual approach depending on the fibroids characteristics and patient needs helps reduce the proportion of hysterectomies for uterine fibroids, preservation of the organ and fertility.

Files

Uterine fibroids_synthesis of modern knowledge.pdf

Files (517.7 kB)

Additional details

References

  • Adusumilli, S., Hussain, H.K., Caoili, E.M., et al. "MRI of sonographically indeterminate adnexal masses." Am J Roentgenol 187.3 (2006): 732–40. DOI: 10.2214/ajr.05.0905
  • Akhter, S., Jahan, K., Afrose, R., et al. "Risk Association, Clinical Presentation and Management of Uterine Leiomyoma." Mymensingh Med J 30.4 (2021): 907–12.
  • Al-Hendy, A., Salama, S. "Gene therapy and Uterine Leiomyoma: A Review." Hum Reprod Update 12.4 (2006): 385–400. DOI: 10.1093/humupd/dml015
  • Ang, W.C., Farrell, E., Vollenhoven, B. "Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: A literature review." Climacteric 4.4 (2001): 284–92. DOI: 10.1080/cmt.4.4.284.292
  • Arthur, R., Kachura, J., Liu, G., et al. "Laparoscopic myomectomy versus uterine artery embolization: Long-term impact on markers of Ovarian Reserve." J Obstet Gynaecol Canada 36.3 (2014): 240–7. DOI: 10.1016/s1701-2163(15)30632-0
  • Bian, M.L., Huang, M.L., Zhang, Z.Y., et al. "Preoperative treatment of uterine fibroids with low-dose mifepristone: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study." Zhonghua Fu Chan Ke Za Zhi 56.5 (2021): 317–27. DOI: 10.3760/cma.j.cn112141-20210411-00192
  • Borah, B.J., Nicholson, W.K., Bradley, L., Stewart, E.A. "The impact of uterine leiomyomas: A national survey of affected women." Am J Obstet Gynecol 209.4 (2013). DOI: 10.1016/j.ajog.2013.07.017
  • Bradley, L.D., Falcone, T., Magen, A.B. "Radiographic imaging techniques for the diagnosis of abnormal uterine bleeding." Obstet Gynecol Clin North Am 27.2 (2000): 245–76. DOI: 10.1016/s0889-8545(00)80019-4
  • Britten, J.L., Malik, M., Levy, G., et al. "Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production." Fertil Steril 98.5 (2012): 1299–1307. DOI: 10.1016/j.fertnstert.2012.07.1123
  • Bulun, S.E. "Uterine fibroids." N Engl J Med 369.14 (2013): 1344–55. DOI: 10.1056/nejmra1209993
  • Cantuaria, G. "Comparison of bimanual examination with ultrasound examination before hysterectomy for uterine leiomyoma." Obstet Gynecol 92.1 (1998): 109–12. DOI: 10.1016/s0029-7844(98)00131-8
  • Chang, I.K.J., Hong, G.Y., Oh, Y.L., et al. "Effects of menopausal hormone therapy on uterine myoma in menopausal women." J Menopausal Med 19.3 (2013): 123. DOI: 10.6118/jmm.2013.19.3.123
  • Chen, Y., Xiong, N., Xiao, J., et al. "Association of uterine fibroids with increased blood pressure: a cross-sectional study and meta-analysis." Hypertens Res 45.4 (2022): 715–21. DOI: 10.1038/s41440-022-00856-w
  • da Silva, F., Pabalan, N., Ekaratcharoenchai, N., et al. "PROGINS Polymorphism of the Progesterone Receptor Gene and the Susceptibility to Uterine Leiomyomas: A Systematic Review and Meta-Analysis." Genetic testing and molecular biomarkers 22.5 (2018): 295–301. DOI: 10.1089/gtmb.2017.0233
  • Day Baird, D., Dunson, D.B., Hill, M.C., et al. "High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence." Am J Obstet Gynecol 188.1 (2003): 100–7. DOI: 10.1067/mob.2003.99
  • Deng, L., Wu, T., Chen, X.Y., et al. "Selective estrogen receptor modulators (SERMs) for uterine leiomyomas." Cochrane Database Syst Rev 10 (2012): CD005287. DOI: 10.1002/14651858.cd005287.pub4
  • DeWaay, D.J., Syrop, C.H., Nygaard, I.E., et al. "Natural history of uterine polyps and Leiomyomata." Obstet Gynecol 100.1 (2002): 3–7. DOI: 10.1097/00006250-200207000-00002
  • Dicle, O., Küçükler, C., Pirnar, T., et al. "Magnetic resonance imaging evaluation of incision healing after cesarean sections." Eur Radiol 7.1 (1997): 31–4. DOI: 10.1007/s003300050103
  • Donnez, J., Tatarchuk, T.F., Bouchard, P., et al. "Ulipristal acetate versus placebo for fibroid treatment before surgery." N Engl J Med 366.5 (2012): 409–20. DOI: 10.1056/nejmoa1103182
  • Donnez, J., Tomaszewski, J., Vázquez, F., et al. "Ulipristal acetate versus leuprolide acetate for uterine fibroids." N Engl J Med 366.5 (2012): 421–32. DOI: 10.1056/nejmoa1103180
  • El Shamy, T., Amer, S.A., Mohamed, A.A., et al. "The impact of uterine artery embolization on Ovarian Reserve: A systematic review and meta-analysis." Acta Obstetricia Et Gynecologica Scandinavica 99.1 (2019): 16–23. DOI: 10.1111/aogs.13698
  • Elkafas, H., Badary, O., Elmorsy, E., et al. "Endocrine-Disrupting Chemicals and Vitamin D Deficiency in the Pathogenesis of Uterine Fibroids." J Adv Pharm Res 5.2 (2021): 260–75. DOI: 10.21608/aprh.2021.66748.1124
  • Emanuel, M.H., Wamsteker, K. "Fluid absorption during transcervical resection of submucous myomas related to the degree of intramural extension." J Am Assoc Gynecol Laparosc 2.4 (1995). DOI: 10.1016/s1074-3804(05)80501-8
  • Englund, K., Blanck, A., Gustavsson, I., et al. "Sex steroid receptors in human myometrium and fibroids: Changes during the menstrual cycle and gonadotropin-releasing hormone treatment." J Clin Endocrinol Metab 83.11 (1998): 4092–6. DOI: 10.1210/jcem.83.11.5287
  • Flake, G.P., Andersen, J., Dixon, D. "Etiology and pathogenesis of uterine leiomyomas: A review." Environmental Health Perspectives 111.8 (2003): 1037–54. DOI: 10.1289/ehp.5787
  • Friedman, A.J., Hoffman, D.I., Comite, F., et al. "Treatment of leiomyomata uteri with leuprolide acetate depot: A double-blind, placebo-controlled, multicenter study." Int J Gynecol Obstet 38.2 (1992): 149. DOI: 10.1016/0020-7292(92)90069-u
  • García, C.-R. "Management of the symptomatic fibroid in women older than 40 years of age." Obstet Gynecol Clin North Am 20.2 (1993): 337–48. DOI: 10.1016/s0889-8545(21)00523-4
  • Ghanaati, H., Sanaati, M., Shakiba, M., et al. "Pregnancy and its outcomes in patients after uterine fibroid embolization: A systematic review and meta-analysis." Cardiovasc Intervent Radiol 43.8 (2020): 1122–33. DOI: 10.1007/s00270-020-02521-6
  • Go, V., Thomas, M.C., Singh, B., et al. "A systematic review of the psychosocial impact of fibroids before and after treatment." Am J Obstet Gynecol 223.5 (2020): 674–708.e8. DOI: 10.1016/j.ajog.2020.05.044
  • Graif, A., Leung, D.A., McKenna, G., et al. "Evaluation of the effect of routine antibiotic administration after uterine artery embolization on infection rates." J Vasc Intervent Radiol 31.8 (2020): 1263–9. DOI: 10.1016/j.jvir.2020.03.026
  • Holdsworth-Carson, S.J., Zaitseva, M., Vollenhoven, B.J., Rogers, P.A.W. "Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues." MHR: Basic Science of Reproductive Medicine 20.3 (2013): 250–9. DOI: 10.1093/molehr/gat083
  • Hoshiai, H., Seki, Y., Kusumoto, T., et al. "Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial." BMC Women's Health 21.1 (2021): 375. DOI: 10.1186/s12905-021-01475-2
  • Ip, P.P., Tse, K.Y., Tam, K.F. "Uterine smooth muscle tumors other than the ordinary leiomyomas and Leiomyosarcomas: A review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy." Adv Anat Pathol 17.2 (2010): 91–112. DOI: 10.1097/pap.0b013e3181cfb901
  • Jin, C., Hu, Y., Chen, X.-C., et al. "Laparoscopic versus open myomectomy – a meta-analysis of randomized controlled trials." Eur J Obstet Gynecol Reprod Biol 145.1 (2009): 14–21. DOI: 10.1016/j.ejogrb.2009.03.009
  • Karlsen, K., Hrobjartsson, A., Korsholm, M., et al. "Fertility after uterine artery embolization of fibroids: A systematic review." Arch Gynecol Obstet 297.1 (2017): 13–25. DOI: 10.1007/s00404-017-4566-7
  • Ke, L.-Q., Yang, K., Li, J., Li, C.-M. "Danazol for uterine fibroids." Cochrane Database Syst Rev 3 (2009): CD007692. DOI: 10.1002/14651858.cd007692
  • Khaw, S.C., Anderson, R.A., Lui, M.-W. "Systematic review of pregnancy outcomes after fertility-preserving treatment of uterine fibroids." Reprod BioMed Online 40.3 (2020): 429–44. DOI: 10.1016/j.rbmo.2020.01.003
  • Kim, C.-W., Shim, H.S., Jang, H., Song, Y.G. "The effects of uterine artery embolization on Ovarian Reserve." Eur J Obstet Gynecol Reprod Biol 206 (2016): 172–6. DOI: 10.1016/j.ejogrb.2016.09.001
  • Kounidas, G., Kastora, S.L., Barnott, E., et al. "Efficacy of ulipristal acetate in women with fibroid induced menorrhagia: A systematic review and meta-analysis." J Gynecol Obstet Hum Reprod 50.9 (2021): 102173. DOI: 10.1016/j.jogoh.2021.102173
  • Kröncke, T., David, M. "Uterine artery embolization (UAE) for fibroid treatment – results of the 5th radiological gynecological expert meeting." Geburtshilfe Und Frauenheilkunde 75.05 (2015): 439–41. DOI: 10.1055/s-0035-1545999
  • Lasmar, R.B., Xinmei, Z., Indman, P.D., et al. "Feasibility of a new system of classification of Submucous Myomas: A multicenter study." Fertil Steril 95.6 (2011): 2073–7. DOI: 10.1016/j.fertnstert.2011.01.147
  • Leibsohn, S., d'Ablaing, G., Mishell, D.R., Schlaerth, J.B. "Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas." Am J Obstet Gynecol 162.4 (1990): 968–76. DOI: 10.1016/0002-9378(90)91298-q
  • Lin, Y., Wu, R.C., Huang, Y.L., et al. "Uterine fibroid-like tumors: spectrum of MR imaging findings and their differential diagnosis." Abdom Radiol (New York) 47.6 (2022): 2197–208. DOI: 10.1007/s00261-022-03431-6
  • Lohle, P.N.M., Higué, D., Herbreteau, D. "Uterine artery embolisation in women with symptomatic uterine fibroids." La Presse Médicale 48.4 (2019): 440–6. DOI: 10.1016/j.lpm.2019.03.012
  • Machado-Lopez, A., Alonso, R., Lago, V., et al. "Integrative Genomic and Transcriptomic Profiling Reveals a Differential Molecular Signature in Uterine Leiomyoma versus Leiomyosarcoma." Int J Mol Sci 23.4 (2022): 2190. DOI: 10.3390/ijms23042190
  • Magalhães, J., Aldrighi, J.M., de Lima, G.R. "Uterine volume and menstrual patterns in users of the Levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas." Contraception 75.3 (2007): 193–8. DOI: 10.1016/j.contraception.2006.11.004
  • Marshall, L. "Variation in the incidence of uterine leiomyoma among premenopausal women by age and race." Obstet Gynecol 90.6 (1997): 967–73. DOI: 10.1016/s0029-7844(97)00534-6
  • Maruo, T., Ohara, N., Yoshida, S., et al. "Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system." Contraception 82.5 (2010): 435–41. DOI: 10.1016/j.contraception.2010.05.006
  • McLucas, B., Voorhees, W.D., Snyder, S.A. "Anti-müllerian hormone levels before and after uterine artery embolization." Minim Invasive Ther Allied Technol 27.3 (2017): 186–90. DOI: 10.1080/13645706.2017.1365728
  • Mlodawska, O.W., Saini, P., Parker, J.B., et al. "Epigenomic and enhancer dysregulation in uterine leiomyomas." Hum Reprod Update (2022): dmac008. DOI: 10.1093/humupd/dmac008
  • Moro, E., Degli Esposti, E., Borghese, G., et al. "The impact of hormonal replacement treatment in postmenopausal women with uterine fibroids: A state-of-the-art review of the literature." Medicina 55.9 (2019): 549. DOI: 10.3390/medicina55090549
  • Muhammad, J., Yusof, Y., Ahmad, I., Norhayati, M.N. "Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis." BMC Women's Health 22.1 (2022): 14. DOI: 10.1186/s12905-022-01596-2
  • Munro, M.G., Critchley, H.O.D., Broder, M.S., Fraser, I.S. "FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age." Int J Gynecol Obstet 113.1 (2011): 3–13. DOI: 10.1016/j.ijgo.2010.11.011
  • Myers, E. "Management of uterine leiomyomata: What do we really know?" Obstet Gynecol 100.1 (2002): 8–17. DOI: 10.1016/s0029-7844(02)02019-7
  • Panidis, D., Vavilis, D., Rousso, D., et al. "Danazol influences gonadotropin secretion acting at the hypothalamic level." Int J Gynecol Obstet 45.3 (1994): 241–6. DOI: 10.1016/0020-7292(94)90249-6
  • Parker, W.H., Fu, Y.S., Berek, J.S. "Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma." Obstet Gynecol 83.4 (1994): 14–8.
  • Peddada, S.D., Laughlin, S.K., Miner, K., et al. "Growth of uterine leiomyomata among premenopausal black and white women." Proceedings of the National Academy of Sciences 105.50 (2008): 19887–92. DOI: 10.1073/pnas.0808188105
  • Pérez-Roncero, G.R., López-Baena, M.T., Ornat, L., et al. "Uterine fibroids and preterm birth risk: A systematic review and meta-analysis." J Obstet Gynaecol Res 46.9 (2020): 1711–27. DOI: 10.1111/jog.14343
  • Qin, H., Lin, Z., Vásquez, E., et al. "Association between obesity and the risk of uterine fibroids: a systematic review and meta-analysis." J Epidemiol Community Health 75.2 (2021): 197–204. DOI: 10.1136/jech-2019-213364
  • Reissmann, T., Diedrich, K., Comaru-Schally, A.M., Schally, A.V. "Introduction of LHRH-antagonists into the treatment of Gynaecological Disorders." Hum Reprod 9.5 (1994): 767–9. DOI: 10.1093/oxfordjournals.humrep.a138593
  • Russ, M., Hees, K.A., Kemmer, M., et al. "Preoperative Uterine Artery Embolization in Women Undergoing Uterus-Preserving Myomectomy for Extensive Fibroid Disease: A Retrospective Analysis." Gynecol Obstet Invest 1.87 (2022): 38–45. DOI: 10.1159/000521914
  • Sayed, G.H., Zakherah, M.S., El-Nashar, S.A., Shaaban, M.M. "A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia." Int J Gynecol Obstet 112.2 (2010): 126–30. DOI: 10.1016/j.ijgo.2010.08.009
  • Sinha, R., Hegde, A., Warty, N., Patil, N. "Laparoscopic excision of very large myomas." J Am Assoc Gynecol Laparosc 10.4 (2003): 461–8. DOI: 10.1016/s1074-3804(05)60145-4
  • Song, H., Lu, D.H., Navaratnam, K., Shi, G. "Aromatase inhibitors for uterine fibroids." Cochrane Database Syst Rev 10 (2013): CD009505. DOI: 10.1002/14651858.cd009505.pub2
  • Spyropoulou, K., Kosmas, I., Tsakiridis, I., et al. "Myomectomy during pregnancy: A systematic review." Eur J Obstet Gynecol Reprod Biol 254 (2020): 15–24. DOI: 10.1016/j.ejogrb.2020.08.018
  • Sumitani, H., Shozu, M., Segawa, T., et al. "In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism". Endocrinology 141.10 (2000): 3852–61. DOI: 10.1210/endo.141.10.7719
  • Suzuki, A., Aoki, M., Miyagawa, C., et al. "Differential diagnosis of uterine leiomyoma and uterine sarcoma using magnetic resonance images: A literature review." Healthcare 7.4 (2019): 158. DOI: 10.3390/healthcare7040158
  • Tatarchuk, T.F., Kosey, N.V., Regeda, S.I., et al. "To the question on uterine fibroids during pregnancy." Scientific Digest of Association of Obstetricians and Gynecologists of Ukraine 1.47 (2021): 54–9. DOI: 10.35278/2664-0767.1(47).2021.242698
  • Templeman, C., Marshall, S.F., Clarke, C.A., et al. "Risk factors for surgically removed fibroids in a large cohort of teachers." Fertil Steril 92.4 (2009): 1436–46. DOI: 10.1016/j.fertnstert.2008.08.074
  • Travaglino, A., Raffone, A., Gencarelli, A., et al. "p53, p16 and ki67 as immunohistochemical prognostic markers in uterine smooth muscle tumors of uncertain malignant potential (STUMP)." Pathol Res Pract 226 (2021): 153592. DOI: 10.1016/j.prp.2021.153592
  • Tsai, M.C., Chang, L.T., Tam, K.W. "Comparison of High-Intensity Focused Ultrasound and Conventional Surgery for Patients with Uterine Myomas: A Systematic Review and Meta-Analysis." J Minim Invasive Gynecol 28.10 (2021): 1712–24. DOI: 10.1016/j.jmig.2021.06.002
  • Tsikouras, P., Manav, B., Koukouli, Z., et al. "Ovarian Reserve after fibroid embolization in premenopausal women." Minim Invasive Ther Allied Technol 26.5 (2017): 284–91. DOI: 10.1080/13645706.2017.1292919
  • Vahdat, M., Allahqoli, L., Mirzaei, H., et al. "The effect of vitamin D on recurrence of uterine fibroids: A randomized, double-blind, placebo-controlled pilot study." Complement Ther Clin Pract 46 (2022): 101536. DOI: 10.1016/j.ctcp.2022.101536
  • Vercellini, P., Giorgio Crosignani, P., Mangioni, C., et al. "Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: Results of a multicentre, randomised controlled trial." BJOG 105.11 (1998): 1148–54. DOI: 10.1111/j.1471-0528.1998.tb09967.x
  • Vilos, G.A., Marks, J., Ettler, H.C., et al. "Uterine smooth muscle tumors of uncertain malignant potential: Diagnostic challenges and therapeutic dilemmas. Report of 2 cases and review of the literature." J Minim Invasive Gynecol 19.3 (2012): 288–95. DOI: 10.1016/j.jmig.2011.12.025
  • Vilos, G.A., Ternamian, A., Dempster, J., et al. "Laparoscopic entry: A review of techniques, technologies, and complications." J Obstet Gynaecol Canada 29.5 (2007): 433–47. DOI: 10.1016/s1701-2163(16)35496-2
  • Vitagliano, A., Noventa, M., Di Spiezio Sardo, A., et al. "Uterine fibroid size modifications during pregnancy and puerperium: Evidence from the first systematic review of literature." Arch Gynecol Obstet 297.4 (2017): 823–35. DOI: 10.1007/s00404-017-4621-4
  • Wise, L.A., Thomas, L., Anderson, S., et al. "Route of myomectomy and fertility: A prospective cohort study." Fertil Steril 117.5 (2022): 1083–93. DOI: 10.1016/j.fertnstert.2022.01.013
  • Xu, F., Deng, L., Zhang, L., et al. "The comparison of myomectomy, UAE and MRgFUS in the treatment of uterine fibroids: a metaanalysis." Int J Hyperthermia 38.2 (2021): 24–9. DOI: 10.1080/02656736.2021.1933216
  • Yan, L., Huang, H., Lin, J., Yu, R. "High-intensity focused ultrasound treatment for symptomatic uterine fibroids: a systematic review and meta-analysis." Int J Hyperthermia 39.1 (2022): 230–8. DOI: 10.1080/02656736.2022.2029956
  • Zhang, J., Go, V.A., Blanck, J.F., Singh, B. "A Systematic Review of Minimally Invasive Treatments for Uterine Fibroid-Related Bleeding." Reprod Sci (2021). DOI: 10.1007/s43032-021-00722-z